Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 2
1947 2
1948 4
1949 2
1950 6
1951 29
1952 45
1953 41
1954 44
1955 45
1956 20
1957 21
1958 15
1959 16
1960 35
1961 28
1962 31
1963 76
1964 205
1965 106
1966 135
1967 194
1968 279
1969 305
1970 395
1971 452
1972 506
1973 607
1974 665
1975 715
1976 736
1977 743
1978 818
1979 889
1980 1019
1981 1017
1982 1220
1983 1479
1984 1724
1985 2097
1986 2105
1987 2384
1988 2630
1989 2976
1990 3377
1991 3449
1992 3641
1993 4019
1994 4148
1995 4355
1996 4617
1997 4652
1998 4907
1999 5108
2000 5868
2001 6176
2002 6631
2003 7178
2004 7815
2005 8255
2006 9031
2007 9424
2008 9778
2009 10457
2010 11541
2011 12269
2012 13068
2013 13124
2014 14100
2015 14889
2016 14446
2017 14044
2018 14121
2019 14420
2020 14959
2021 14811
2022 14012
2023 12466
2024 6904

Text availability

Article attribute

Article type

Publication date

Search Results

317,877 results

Results by year

Filters applied: . Clear all
Page 1
The future of peptides in cancer treatment.
Kurrikoff K, Aphkhazava D, Langel Ü. Kurrikoff K, et al. Curr Opin Pharmacol. 2019 Aug;47:27-32. doi: 10.1016/j.coph.2019.01.008. Epub 2019 Mar 8. Curr Opin Pharmacol. 2019. PMID: 30856511 Review.
Peptides hold great potential for the cancer therapy and diagnostics. In the current review, the main and most influential areas of peptide cancer therapeutics are overviewed. These include the development of anticancer peptides, u
Peptides hold great potential for the cancer therapy and diagnostics. In the current review, the main and most influent
The Potential Use of Peptides in Cancer Treatment.
Yavari B, Mahjub R, Saidijam M, Raigani M, Soleimani M. Yavari B, et al. Curr Protein Pept Sci. 2018;19(8):759-770. doi: 10.2174/1389203719666180111150008. Curr Protein Pept Sci. 2018. PMID: 29332577 Review.
This review highlights recent advances in and future prospects for the application of peptides as therapeutic agents for cancer therapy. We discuss the application of peptides in cancer therapy, alone and in combination with other pept
This review highlights recent advances in and future prospects for the application of peptides as therapeutic agents for cancer
Novel Peptide Therapeutic Approaches for Cancer Treatment.
Li CM, Haratipour P, Lingeman RG, Perry JJP, Gu L, Hickey RJ, Malkas LH. Li CM, et al. Cells. 2021 Oct 27;10(11):2908. doi: 10.3390/cells10112908. Cells. 2021. PMID: 34831131 Free PMC article. Review.
Peptides are increasingly being developed for use as therapeutics to treat many ailments, including cancer. ...In this review, we discuss strategies recently developed to overcome these obstacles of peptide delivery and bioavailability. In addition, we
Peptides are increasingly being developed for use as therapeutics to treat many ailments, including cancer. ...In this
mRNA-based cancer therapeutics.
Liu C, Shi Q, Huang X, Koo S, Kong N, Tao W. Liu C, et al. Nat Rev Cancer. 2023 Aug;23(8):526-543. doi: 10.1038/s41568-023-00586-2. Epub 2023 Jun 13. Nat Rev Cancer. 2023. PMID: 37311817 Review.
With the aim of encoding tumour antigens for cancer vaccines, cytokines for immunotherapy, tumour suppressors to inhibit tumour development, chimeric antigen receptors for engineered T cell therapy or genome-editing proteins for gene therapy, many of these …
With the aim of encoding tumour antigens for cancer vaccines, cytokines for immunotherapy, tumour suppressors to inhibit tumour devel …
Venom Peptides and Toxins - A Prospective Spearhead in Cancer Treatment.
Wong JPC, Li B, Kwok HF. Wong JPC, et al. Comb Chem High Throughput Screen. 2017;20(5):357-375. doi: 10.2174/1386207320666170621130425. Comb Chem High Throughput Screen. 2017. PMID: 28637411 Review.
Many treatments have been adopted to reduce cancer cell proliferation; however, new mutated developments of some cancer cells have started to show resistance towards current therapies and treatments that cause some drugs to lose their efficacy. Additio …
Many treatments have been adopted to reduce cancer cell proliferation; however, new mutated developments of some cancer
Biomedical Relevance of Novel Anticancer Peptides in the Sensitive Treatment of Cancer.
Bakare OO, Gokul A, Wu R, Niekerk LA, Klein A, Keyster M. Bakare OO, et al. Biomolecules. 2021 Jul 29;11(8):1120. doi: 10.3390/biom11081120. Biomolecules. 2021. PMID: 34439786 Free PMC article. Review.
Anticancer peptides (ACPs) are a subset of host defense peptides, also known as antimicrobial peptides, which have emerged as therapeutic and diagnostic candidates due to several compensatory advantages over the non-specificity of the current treatment
Anticancer peptides (ACPs) are a subset of host defense peptides, also known as antimicrobial peptides, which have emer …
Harnessing cytokines and chemokines for cancer therapy.
Propper DJ, Balkwill FR. Propper DJ, et al. Nat Rev Clin Oncol. 2022 Apr;19(4):237-253. doi: 10.1038/s41571-021-00588-9. Epub 2022 Jan 7. Nat Rev Clin Oncol. 2022. PMID: 34997230 Review.
During the past 40 years, cytokines and cytokine receptors have been extensively investigated as either cancer targets or cancer treatments. A strong preclinical rationale supports therapeutic strategies to enhance the growth inhibitory and immunostimulatory …
During the past 40 years, cytokines and cytokine receptors have been extensively investigated as either cancer targets or cancer
Evaluation of the use of therapeutic peptides for cancer treatment.
Marqus S, Pirogova E, Piva TJ. Marqus S, et al. J Biomed Sci. 2017 Mar 21;24(1):21. doi: 10.1186/s12929-017-0328-x. J Biomed Sci. 2017. PMID: 28320393 Free PMC article. Review.
Conventional cancer treatments are losing their therapeutic uses due to drug resistance, lack of tumour selectivity and solubility and as such there is a need to develop new therapeutic agents. Therapeutic peptides are a promising and a novel approach to trea …
Conventional cancer treatments are losing their therapeutic uses due to drug resistance, lack of tumour selectivity and solubi …
Peptides, proteins and nanotechnology: a promising synergy for breast cancer targeting and treatment.
Sorolla A, Sorolla MA, Wang E, Ceña V. Sorolla A, et al. Expert Opin Drug Deliv. 2020 Nov;17(11):1597-1613. doi: 10.1080/17425247.2020.1814733. Epub 2020 Sep 11. Expert Opin Drug Deliv. 2020. PMID: 32835538 Review.
However, there are still many areas of improvement which can certainly be addressed with the use of peptide-based elements. AREAS COVERED: The article reviews different preclinical strategies employing peptides and proteins in combination with nanoparticles for brea …
However, there are still many areas of improvement which can certainly be addressed with the use of peptide-based elements. AREAS COV …
Targeting STAT3 in Cancer Immunotherapy.
Zou S, Tong Q, Liu B, Huang W, Tian Y, Fu X. Zou S, et al. Mol Cancer. 2020 Sep 24;19(1):145. doi: 10.1186/s12943-020-01258-7. Mol Cancer. 2020. PMID: 32972405 Free PMC article. Review.
As a point of convergence for numerous oncogenic signaling pathways, signal transducer and activator of transcription 3 (STAT3) is central in regulating the anti-tumor immune response. STAT3 is broadly hyperactivated both in cancer and non-cancerous cells within the …
As a point of convergence for numerous oncogenic signaling pathways, signal transducer and activator of transcription 3 (STAT3) is central i …
317,877 results
You have reached the last available page of results. Please see the User Guide for more information.